Literature DB >> 12358859

Molecular cloning of agonistic and antagonistic monoclonal antibodies against human 4-1BB.

U-H Lee1, K B Kwack, J-W Park, B S Kwon.   

Abstract

Previously, we prepared two different monoclonal antibodies (mAbs) against human 4-1BB (CD137): an agonistic mAb BBK-1 and an antagonistic mAb BBK-2. In this paper, we describe the molecular cloning of these two mAbs and present comparisons of their amino acid sequences. cDNAs encoding the heavy (H) and light (L) chains of the two mAbs were cloned by screening of cDNA libraries constructed from hybridomas secreting these mAbs. Comparisons of amino acid sequences of the two mAbs showed that, while the constant regions of the H and L chains were identical between the two mAbs, the variable region showed 45% identity in H chains and 48% identity in L chains. This suggests that these two mAbs recognize different epitopes of 4-1BB and may have different effects on the activity of 4-1BB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358859     DOI: 10.1046/j.1365-2370.2002.00351.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  2 in total

1.  In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).

Authors:  De-Gang Song; Qunrui Ye; Carmine Carpenito; Mathilde Poussin; Li-Ping Wang; Chunyan Ji; Mariangela Figini; Carl H June; George Coukos; Daniel J Powell
Journal:  Cancer Res       Date:  2011-05-05       Impact factor: 12.701

2.  CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.

Authors:  Matthew W Anderson; Shuchun Zhao; Aharon G Freud; Debra K Czerwinski; Holbrook Kohrt; Ash A Alizadeh; Roch Houot; Denize Azambuja; Irene Biasoli; José Carlos Morais; Nelson Spector; Hernan F Molina-Kirsch; Roger A Warnke; Ronald Levy; Yasodha Natkunam
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.